Literature DB >> 15831735

Addiction research. Ibogaine therapy: a 'vast, uncontrolled experiment'.

Brian Vastag.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15831735     DOI： 10.1126/science.308.5720.345

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  8 in total

Review 1.  Reward, addiction, withdrawal to nicotine.

Authors:  Mariella De Biasi; John A Dani
Journal:  Annu Rev Neurosci       Date:  2011       Impact factor: 12.449

2.  "Research chemicals": tryptamine and phenethylamine use among high-risk youth.

Authors:  Bill Sanders; Stephen E Lankenau; Jennifer Jackson Bloom; Dodi Hathazi
Journal:  Subst Use Misuse       Date:  2008       Impact factor: 2.164

Review 3.  Ibogaine-associated cardiac arrest and death: case report and review of the literature.

Authors:  Jessica A Meisner; Susan R Wilcox; Jeremy B Richards
Journal:  Ther Adv Psychopharmacol       Date:  2016-01-13

4.  Anti-addiction drug ibogaine inhibits hERG channels: a cardiac arrhythmia risk.

Authors:  Xaver Koenig; Michael Kovar; Stefan Boehm; Walter Sandtner; Karlheinz Hilber
Journal:  Addict Biol       Date:  2012-03-28       Impact factor: 4.280

Review 5.  The anti-addiction drug ibogaine and the heart: a delicate relation.

Authors:  Xaver Koenig; Karlheinz Hilber
Journal:  Molecules       Date:  2015-01-29       Impact factor: 4.411

6.  Ibogaine Detoxification Transitions Opioid and Cocaine Abusers Between Dependence and Abstinence: Clinical Observations and Treatment Outcomes.

Authors:  Deborah C Mash; Linda Duque; Bryan Page; Kathleen Allen-Ferdinand
Journal:  Front Pharmacol       Date:  2018-06-05       Impact factor: 5.810

7.  Anti-addiction drug ibogaine inhibits voltage-gated ionic currents: a study to assess the drug's cardiac ion channel profile.

Authors:  Xaver Koenig; Michael Kovar; Lena Rubi; Agnes K Mike; Peter Lukacs; Vaibhavkumar S Gawali; Hannes Todt; Karlheinz Hilber; Walter Sandtner
Journal:  Toxicol Appl Pharmacol       Date:  2013-05-22       Impact factor: 4.219

8.  Anti-addiction Drug Ibogaine Prolongs the Action Potential in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.

Authors:  Lena Rubi; Daniel Eckert; Stefan Boehm; Karlheinz Hilber; Xaver Koenig
Journal:  Cardiovasc Toxicol       Date:  2017-04       Impact factor: 3.231
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.